The Lymphocyte-to-Monocyte Ratio (LMR) as a Novel Biomarker for Cervical Cancer Risk Stratification in Conization Patients. Szabo V, Varbiro S, Kalas N, Vida B, et al. J Clin Med 2025;14:6057.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Szabo V, Varbiro S, Kalas N, Vida B, et al. The Lymphocyte-to-Monocyte Ratio (LMR) as a Novel Biomarker for Cervical Cancer Risk Stratification in Conization Patients. J Clin Med 2025;14:6057.
PMID: 40943817